Category
All topics News Innovation Publications
Language
All languages English French
Sort by
Most recent Oldest A–Z

146 items

Revised FDA guidance on Generic Transdermal and Topical Delivery Systems
July 03, 2023
English
Revised FDA guidance on Generic Transdermal and Topical Delivery Systems next-arrow
Insight to Acquiring PL License across the United Kingdom from PLGB (Product License Great Britain) or PLNI (Product License Northern Ireland)
June 15, 2023
English
Insight to Acquiring PL License across the United Kingdom from PLGB (Product License Great Britain) or PLNI (Product License Northern Ireland) next-arrow
Evaluation of prospective service providers: Supervision of the relationship with service provider for pharmacovigilance
June 14, 2023
English
Evaluation of prospective service providers: Supervision of the relationship with service provider for pharmacovigilance next-arrow
PLG
June 13, 2023
English
UK National Contact Person for Pharmacovigilance next-arrow
PLG
June 02, 2023
English
Overcoming Challenges in the Chinese Pharmaceutical Clients: How PLG Solutions Support Client Success next-arrow
CEP 2.0: The Future of Certification of Suitability to the European Pharmacopoeia
May 23, 2023
English
CEP 2.0: The Future of Certification of Suitability to the European Pharmacopoeia next-arrow
Understanding the Nordic market
May 11, 2023
English
Understanding the Nordic market next-arrow
PLG
May 10, 2023
English
Market access: implications of the regional convergence trend on Biopharma and Medtech next-arrow
EU affiliate landscape... A complex web
May 09, 2023
English
EU affiliate landscape... A complex web next-arrow
PLG
April 25, 2023
English
Industry bodies commented on USFDA released M11: technical specification - clinical electronic structured harmonized protocol (CESHARP) next-arrow
PLG
April 25, 2023
English
USFDA Guidance released! For Product-Specific Guidance Meetings for the ANDA applicants next-arrow
PLG
April 20, 2023
English
Responsibilities of the marketing authorization holder concerning the qualified person responsible for pharmacovigilance (QPPV) in the EU next-arrow
Periodic Adverse Drug Experience Report (PADER) in a nutshell
April 20, 2023
English
Periodic Adverse Drug Experience Report (PADER) in a nutshell next-arrow
PLG
April 11, 2023
English
ProductLife Consulting C-Level Event next-arrow
PLG
March 28, 2023
English
Differences in registration requirements for Europe and US market next-arrow
Back 1 2 3 4 5 6 7 8 9 10 Next